Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean population

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2798-2807

  Corella, Dolores ^a,b   Carrasco, Paula ^a,b   Fitó, Montserrat ^b,c   Martínez González, Miguel Angel ^d   Salas Salvadó, Jordi ^b,e   Arós, Fernando ^f   Lapetra, José ^b,g   Guillén, Marisa ^a,b   Ortega Azorín, Carolina ^a,b   Warnberg, Julia ^d,h   Fiol, Miquel ^b,i   Ruiz Gutierrez, Valentina ^j   Serra Majem, Lluís ^k   Alfredo Martinez J ^l   Ros, Emilio ^b,m   Estruch, Ramón ^b,n  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^f HOSPITAL TXAGORRITXU   (Spain)

^g Primary Care Center Sevilla Norte   (Spain)

^h UNIVERSITY OF MÁLAGA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^j INSTITUTO DE LA GRASA   (Spain)

^k UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^l UNIVERSITY OF NAVARRA   (Spain)

^m INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

ⁿ HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

Alcohol; Fat; Lipids; Mediterranean diet; Nutrigenetics; Obesity

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FAT INTAKE; FEMALE; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SOUTHERN EUROPE;

EID: 77956825620     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P005199     Document Type: Article

References (49)

1. Aulchenko, Y. S., S. Ripatti, I. Lindqvist, D. Boomsma, I. M. Heid, P. P. Pramstaller, B. W. Penninx, A. C. Janssens, J. F. Wilson, T. Spector, et al. 2009. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41: 47-55.
2. Hiura, Y., Y. Hiura, C. S. Shen, Y. Kokubo, T. Okamura, T. Morisaki, H. Tomoike, T. Yoshida, H. Sakamoto, Y. Goto, et al. 2009. Identification of genetic markers associated with high-density lipoprotein-cholesterol by genome-wide screening in a Japanese population: the Suita study. Circ. J. 73: 1119-1126.
3. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havullina, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.
4. Kathiresan, S., C. J. Willer, G. M. Peloso, S. Demissie, K. Musunuru, E. E. Schadt, L. Kaplan, D. Bennett, Y. Li, T. Tanaka, et al. 2009. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41: 56-65.
5. Hausenloy, D. J., and D. M. Yellon. 2008. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Postgrad. Med. J. 84: 590-598.
6. Barkowski, R. S., and W. H. Frishman. 2008. HDL metabolism and CETP inhibition. Cardiol. Rev. 16: 154-162.
7. Kastelein, J. J., S. I. van Leuven, L. Burgess, G. W. Evans, J. A. Kuivenhoven, P. J. Barter, J. H. Revkin, D. E. Grobbee, W. A. Riley, C. L. Shear, et al. 2007. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N. Engl. J. Med. 356: 1620-1630.
8. Nicholls, S. J., E. M. Tuzcu, D. M. Brennan, J. C. Tardif, and S. E. Nissen. 2008. Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation). Circulation. 118: 2506-2514.
9. Ordovas, J. M., L. A. Cupples, D. Corella, J. D. Otvos, D. Osgood, A. Martinez, C. Lahoz, O. Coltell, P. W. Wilson, E. J. Schaeffer. 2000. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler. Thromb. Vasc. Biol. 20: 1323-1329.
10. Lu, H., A. Inazu, Y. Moriyama, T. Higashikata, M. A. Kawashiri, W. Yu, Z. Huang, T. Okamura, and H. Mabuchi. 2003. Haplotype analyses of cholesteryl ester transfer protein gene promoter: a clue to an unsolved mystery of TaqIB polymorphism. J. Mol. Med. 81: 246-255.
11. Frisdal, E., A. H. Klerkx, W. Le Goff, M. W. Tanck, J. P. Lagarde, J. W. Jukema, J. J. Kastelein, M. J. Chapman, and M. Guerin. 2005. Functional interaction between-629C/A,-971G/A and-1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Hum. Mol. Genet. 14: 2607-2618.
12. Boekholdt, S. M., F. M. Sacks, J. W. Jukema, J. Shepherd, D. J. Freeman, A. D. McMahon, F. Cambien, V. Nicaud, G. J. de Grooth, P. J. Talmud, et al. 2005. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation. 111: 278-287.
13. Thompson, A., E. Di Angelantonio, N. Sarwar, S. Erqou, D. Saleheen, R. P. P. Dullaart, B. B. Keavney, Z. Z. Ye, and J. Danesh. 2008. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 299: 2777-2788. (Pubitemid 351846853)
14. Horne, B. D., J. F. Carlquist, L. A. Cannon-Albright, J. B. Muhlestein, J. T. McKinney, M. J. Kolek, J. L. Clarke, J. L. Anderson, and N. J. Camp. 2006. High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann. Hum. Genet. 70: 524-534.
15. Horne, B. D., N. J. Camp, J. L. Anderson, C. P. Mower, J. L. Clarke, M. J. Kolek, and J. F. Carlquist, and Intermountain Heart Collaborative Study Group. 2007. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J. Am. Coll. Cardiol. 49: 2053-2060.
16. Thompson, J. F., L. S. Wood, E. H. Pickering, B. Dechairo, and C. L. Hyde. 2007. High-density genotyping and functional SNP localization in the CETP gene. J. Lipid Res. 48: 434-443.
17. Fumeron, F., D. Betoulle, G. Luc, I. Behague, S. Ricard, O. Poirier, R. Jemaa, A. Evans, D. Arveiler, P. Marques-Vidal, et al. 1995. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96: 1664-1671.
18. Tsujita, Y., Y. Nakamura, Q. Zhang, S. Tamaki, A. Nozaki, K. Amamoto, T. Kadowaki, Y. Kita, T. Okamura, M. Horie, et al. 2007. The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis. 191: 199-205.
19. Jensen, M. K., K. J. Mukamal, K. Overvad, and E. B. Rimm. 2008. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur. Heart J. 29: 104-112.
20. Corella, D., C. Sáiz, M. Guillén, O. Portolés, F. Mulet, J. I. González, and J. M. Ordovás. 2000. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis. 152: 367-376.
21. Chen, J., T. Yokoyama, K. Saito, N. Yoshiike, C. Date, and H. Tanaka. 2002. Association of human cholesteryl ester transfer protein-TaqI polymorphisms with serum HDL cholesterol levels in a normolipemic Japanese rural population. J. Epidemiol. 12: 77-84. (Pubitemid 44137139)
22. Talmud, P. J., E. Hawe, K. Robertson, G. J. Miller, N. E. Miller, and S. E. Humphries. 2002. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann. Hum. Genet. 66: 111-124.
23. Li, T. Y., C. Zhang, F. W. Asselbergs, L. Qi, E. Rimm, D. J. Hunter, and F. B. Hu. 2007. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men. Am. J. Clin. Nutr. 86: 1524-1529.
24. Nettleton, J. A., L. M. Steffen, C. M. Ballantyne, E. Boerwinkle, and A. R. Folsom. 2007. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults. Atherosclerosis. 194: e131-e140.
25. Aitken, W. A., A. W. Chisholm, A. W. Duncan, M. J. Harper, S. E. Humphries, J. I. Mann, C. Murray Skeaff, W. H. Sutherland, A. J. Wallace, and S. M. Williams. 2006. Variation in the cholesteryl ester transfer protein (CETP) gene does not influence individual plasma cholesterol response to changes in the nature of dietary fat. Nutr. Metab. Cardiovasc. Dis. 16: 353-363.
26. Carmena-Ramón, R., J. F. Ascaso, J. T. Real, G. Nájera, J. M. Ordovás, and R. Carmena. 2001. Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and plasma lipoprotein levels in familial hypercholesterolemia. Metabolism. 50: 651-656. (Pubitemid 32551817)
27. Estruch, R., M. A. Martínez-González, D. Corella, J. Salas-Salvadó, V. Ruiz-Gutiérrez, M. I. Covas, M. Fiol, E. Gómez-Gracia, M. C. López-Sabater, E. Vinyoles, et al. 2006. Effects of a Mediterraneanstyle diet on cardiovascular risk factors: a randomized trial. Ann. Intern. Med. 145: 1-11.
28. Martin-Moreno, J. M., P. Boyle, L. Gorgojo, P. Maisonneuve, J. C. Fernandez-Rodriguez, S. Salvini, and W. C. Willett. 1993. Development and validation of a food frequency questionnaire in Spain. Int. J. Epidemiol. 22: 512-519.
29. Mataix, J. Tabla de composición de alimentos [Food composition tables]. Granada (Spain): University of Granada; 2003.
30. Fernández-Ballart, J. D., J. L. Piñol, I. Zazpe, D. Corella, P. Carrasco, E. Toledo, M. Perez-Baue, M. A. Martínez-González, J. Salas-Salvadó, and J. M. Martín-Moreno. 2010. Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain. Br. J. Nutr. 103: 1808-1816.
31. Rimm, E. B., E. L. Giovannucci, M. J. Stampfer, G. A. Colditz, L. B. Litin, and W. C. Willett. 1992. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am. J. Epidemiol. 135: 1114-1126.
32. Molag, M. L., J. H. de Vries, M. C. Ocké, P. C. Dagnelie, P. A. van den Brandt, M. C. Jansen, W. A. van Staveren, and P. van't Veer. 2002. Design characteristics of food frequency questionnaires in relation to their validity. Am. J. Epidemiol. 166: 1468-14 78.
33. Pearson, T. A. 1996. Alcohol and heart disease. Circulation. 94: 3023-3025.
34. Sánchez-Taínta, A., R. Estruch, M. Bulló, D. Corella, E. Gómez-Gracia, M. Fiol, J. Algorta, M. I. Covas, J. Lapetra, I. Zazpe, et al. 2008. Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients. Eur. J. Cardiovasc. Prev. Rehabil. 15: 589-593.
35. Elosua, R., J. Marrugat, L. Molina, S. Pons, and E. Pujol. 1994. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish men. The MARATHOM Investigators. Am. J. Epidemiol. 139: 1197-1209.
36. Friedewald, W. T., R. I. Levy, D. S. Fredrickson. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin. Chem. 18: 499-502.
37. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 285: 2486-2497.
38. Tai, E. S., J. M. Ordovas, D. Corella, M. Deurenberg-Yap, E. Chan, X. Adiconis, S. K. Chew, L. M. Loh, and C. E. Tan. 2003. The TaqIB and-629C>A polymorphisms at the cholesteryl ester transfer protein locus: associations with lipid levels in a multiethnic population. The 1998 Singapore National Health Survey. Clin. Genet. 63: 19-30.
39. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein: the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
40. Natarajan, P., K. K. Ray, C. P. Cannon. 2010. High-density lipoprotein and coronary heart disease: current and future therapies. J. Am. Coll. Cardiol. 55: 1283-1299.
41. Spirin, V., S. Schmidt, A. Pertsemlidis, R. S. Cooper, J. C. Cohen, and S. R. Sunyaev. 2007. Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol. Am. J. Hum. Genet. 81: 6.
42. Sofat, R., A. D. Hingorani, L. Smeeth, S. E. Humphries, P. J. Talmud, J. Cooper, T. Shah, M. S. Sandhu, S. L. Ricketts, S. M. Boekholdt, et al. 2010. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation. 121: 52-62.
43. Hu, X., J. D. Dietz, C. Xia, D. R. Knight, W. T. Loging, A. H. Smith, H. Yuan, D. A. Perry, and J. Keiser. 2009. Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition. Endocrinology. 150: 2211-2219.
44. Neeli, H., and D. J. Rader. 2008. Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib? Cardiol. Clin. 26: 537-546.
45. Vohl, M. C., B. Lamarche, A. Pascot, G. Leroux, D. Prud'homme, C. Bouchard, A. Nadeau, and J. P. Després. 1999. Contribution of the cholesteryl ester transfer protein gene TaqIB polymorphism to the reduced plasma HDL-cholesterol levels found in abdominal obese men with the features of the insulin resistance syndrome. Int. J. Obes. Relat. Metab. Disord. 23: 918-925.
46. Hodo lugil, U., D. W. Williamson, Y. Huang, and R. W. Mahley. 2005. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin. Genet. 68: 118-127.
47. Corella, D., and J. M. Ordovas. 2009. Nutrigenomics in cardiovascular medicine. Circ Cardiovasc Genet. 2: 637-651.
48. Yamashita, S., K. Tsubakio-Yamamoto, T. Ohama, Y. Nakagawa-Toyama, and M. Nishida. 2010. Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions. J. Atheroscler. Thromb. 17: 436-451.
49. Regieli, J. J., J. W. Jukema, D. E. Grobbee, J. J. Kastelein, J. A. Kuivenhoven, A. H. Zwinderman, Y. van der Graaf, M. L. Bots, and P. A. Doevendans. 2008. CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction. Eur. Heart J. 29: 2792-2799